Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
Top Cited Papers
Open Access
- 12 March 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 95, 183-191
- https://doi.org/10.1016/j.ijid.2020.03.013
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJama-Journal Of The American Medical Association, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020
- An Outbreak of NCIP (2019-nCoV) Infection in China — Wuhan, Hubei Province, 2019−2020China CDC Weekly, 2020
- Trends in admission serum albumin and mortality in patients with hospital readmissionInternational Journal Of Clinical Practice, 2019
- Respiratory failure as a result of chronic impaired ventilation in actualization of insufficient respiration: A case reportTrends in Anaesthesia and Critical Care, 2017
- Elevated troponin in patients with acute stroke – Is it a true heart attack?The Egyptian Heart Journal, 2017
- ForewordKidney International Supplements, 2012
- Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS PatientsEmerging Infectious Diseases, 2004
- Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.2002